MetaCap

Genprex (GNPX) vs Propanc Biopharma (PPCB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Genprex is the larger company by market cap ($1.9 million vs $1.9 million), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

GNPX-44.66%PPCB+256.93%
+409%+171%-67%
Oct 7, 20261 yearNov 20, 2026
GNPX-46.69%PPCB+266.48%
+317%+126%-64%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

GNPX versus PPCB key metrics
MetricGNPXPPCB
Share price$1.45$1.78
Market cap$1.94M$1.87M
1-day change-13.17%+3.19%
P/E ratio (TTM)0.01—
EPS (TTM)$98.47$-95.92
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Net income (latest FY)$-16.23M$-18.86M
52-week high$80.96$315.00
52-week low$1.45$1.61
Distance from 52-week high-98.21%-99.43%
Average volume168.88K188.66K
Shares outstanding1.33M1.05M
Employees132
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Genprex

GNPX stock →

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes.

Health Care · Biotechnology: Pharmaceutical Preparations · 13 employees

About Propanc Biopharma

PPCB stock →

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

GNPX vs PPCB FAQ

Which is bigger, Genprex or Propanc Biopharma?

Genprex (GNPX) is larger, with a market capitalization of $1.94M compared with $1.87M for Propanc Biopharma (PPCB).

Are Genprex and Propanc Biopharma in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons